Gilead Sciences has put $66 million down to start a collaboration with San Diego start-up Tentarix Biotherapeutics to develop new therapeutics for cancer and inflammatory diseases. The agreement ...

Gilead’s new hepatitis C triple therapy Vosevi has been approved in the US, and will largely meet the needs of patients with difficult to treat forms of the disease. The FDA approved Vosevi ...

India, with its rich cultural diversity, is home to some of the oldest and most awe-inspiring churches that offer a unique blend of architecture, heritage, and tranquility. If you’re planning a ...

Polaris Global Equity Strategy highlighted stocks like Gilead Sciences, Inc. (NASDAQ:GILD), in the third quarter 2024 investor letter. Gilead Sciences, Inc. (NASDAQ:GILD) is a biopharmaceutical ...

Biotech giant Gilead Sciences, Inc. GILD has put up a steady performance in 2024 amid a volatile market. Its shares have gained 15.4% in a year against the industry’s decline of 10.8%.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In addition, check the fund’s top five holdings to know its best picks in 2024. Polaris Global Equity Strategy highlighted stocks like Gilead Sciences, Inc. (NASDAQ:GILD), in the third quarter 2024 ...

Blue Cross and Blue Shield (BCBS) is the best health insurance company in Nebraska. Silver plans from BCBS start at $649 per month before discounts.

A structure that was built in 1883 is the home of the Cortland Museum, and local volunteers are working hard to make it a great destination for visitors.

$ 92.22-0.36-0.38% ...